Organon & Co | OGN - Ordinary Share Capital


Organon & Co reported $259.98M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Celltrion KRW 218.78M 1.5M Sep/2025
Cspc Pharmaceutical CNY 11.52B 3.7M Dec/2025
Deva Holding AS TRY 200.02M 0 Sep/2023
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Divis Laboratories Ltd INR 265.47M 264.53M Sep/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
Glaxosmithkline GBP 4.08B 49.43M Dec/2025
Kangmei Pharma CNY 13.83B 34.97M Sep/2025
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Laboratorios Farma EUR 51.82M 1.55M Dec/2023
Malin Corporation EUR 200K 0 Dec/2024
Medical Developments International AUD 112.66M 2.35M Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Organigram Holdings CAD 135.13M 671.75K Dec/2025
Organon & Co USD 259.98M 18K Sep/2025
Ovoca Bio EUR 29.49M 18.43M Jun/2025
Pharma Mar EUR 17.36M 214.99K Dec/2025
Qiagen NV USD 216.56M 284.67K Dec/2025
Sartorius EUR 69.04M 0 Sep/2025
Sino Biopharmaceutical CNY 17.89B 30.5M Jun/2025
Tilray USD 116.52M 5.01M Sep/2025
Zealand Pharma A/S 70.61M 319.68K Dec/2025